Prakiraan wutah bathi kanggo taun ngarep avadel.com (AVDL)

AVDL (avadel.com) - tandha merek perusahaan

Avadel Pharmaceuticals (AVDL) develops narcolepsy medications using a sustained-release formula to scale profits. The company's EPS forecast trends for the coming year visualize expert expectations, where 529.40 determines the latest valuation metric. The business relies on third-party plants for production, while its strategy excludes mergers, focusing instead on independent sales expansion within the US.

Avadel Pharmaceuticals PLC (AVDL): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 04.07.2022 nganti 28.02.2026

Rincian metrik komprehensif lan analitis Avadel Pharmaceuticals plc (AVDL)

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:Avadel Pharmaceuticals plc, AVDL
Produk merek avadel.com

For long-term asset selection, it is critical to balance conservative reliability against the risk of overheated expectations. This indicator measures the percentage change in projected earnings per share (EPS) for the coming year, reflecting the speed of the market's business revaluation, which for Avadel Pharmaceuticals (AVDL), during the launch of its sole drug and the abandonment of mergers, makes the analyst growth chart for EPS the primary metric for measuring direct sales success.

Perusahaan pesaing